Managing the Drug Discovery Process

Walter Moos (SRI International, Menlo Park, CA, USA and University of California-San Francisco, CA, USA),Susan Miller (Professor, Department of Pharmaceutical Chemistry, University of California, San Fransisco, CA, USA),Stephen Munk (President and CEO, Ash Stevens Inc., Riverview, MI, USA),Barbara Munk (Senior Lecturer, Department of Chemistry, Wayne State University, Detroit, MI, USA),David C. Spellmeyer (Nodality, Inc., CA, USA)

Managing the Drug Discovery Process
Format
Paperback
Publisher
Elsevier Science Publishing Co Inc
Country
United States
Published
1 January 2023
Pages
586
ISBN
9780128243046

Managing the Drug Discovery Process

Walter Moos (SRI International, Menlo Park, CA, USA and University of California-San Francisco, CA, USA),Susan Miller (Professor, Department of Pharmaceutical Chemistry, University of California, San Fransisco, CA, USA),Stephen Munk (President and CEO, Ash Stevens Inc., Riverview, MI, USA),Barbara Munk (Senior Lecturer, Department of Chemistry, Wayne State University, Detroit, MI, USA),David C. Spellmeyer (Nodality, Inc., CA, USA)

Managing the Drug Discovery Process, Second Edition thoroughly examines the current state of pharmaceutical research and development by providing chemistry-based perspectives on biomedical research, drug hunting and innovation. The book also considers the interplay of stakeholders, consumers and the drug firm with attendant factors, including those that are technical, legal, economic, demographic, political, social, ecological and infrastructural. This new edition takes a closer look at increasing pre-approval costs for new drugs and examines not only why these increases occur, but also how they can be overcome to ensure a robust pharmacoeconomic future.

Since drug research can be a high-risk, high-payoff industry, it is important to researchers to effectively and strategically manage the drug discovery process. All chapters in this new release have been revised and expanded with new discussions on genetic and epigenetic advances, including CRISPR, exosomes, immuno-oncology approaches, including checkpoint inhibitors and CAR-T, antibiotics, entrepreneurship, and AI.

This item is not currently in-stock. It can be ordered online and is expected to ship in approx 2 weeks

Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.

Sign in or become a Readings Member to add this title to a wishlist.